|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Allergan, Inc., a speciality pharmaceutical company focused on ophthalmology, neurosciences, medical dermatology, medical aesthetics and other specialty markets. |
|---|---|
| Transferring Party | Inamed Corporation, a manufacturer of breast implants, dermal products to treat facial wrinkles, and minimally invasive devices for obesity intervention, including the LAP-BAND® System for morbid obesity. |
| Sector | Medical Devices |
| Date | March 23, 2006 |
| Analysis In this $3.4 billion proposal (countering a lower one by Medici Pharmaceutical Corp.) Allergan (maker of BOTOX) seeks to broaden its portfolio of medical aesthetic products and leverage significant growth and cross-marketing and cross-selling opportunities. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |